Weekly Recap | Johnson & Johnson +0.46%, most brokers rate it buyWeekly Review·59 minutes agoJNJ+0.20%
Weekly Recap | GlucoTrack -26.32%, dilution pressure trims midweek surgeWeekly Review·1 hour agoGCTK-29.46%
Weekly Recap | Abcellera Biologics +0.55%, consensus target above spotWeekly Review·1 hour agoABCL+0.40%
